Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22919640 | 0.98 | NAAA (0.44) | NAAATSHRTP53CYP3A4MAPK1 | |
| SCHEMBL7278773 | 0.98 | NAAA (0.44) | NAAATSHRTP53CYP3A4MAPK1 | |
| Bicarbonate SCHEMBL27875196 | 0.97 | NAAA (0.40) | NAAATSHRTP53CYP3A4MAPK1 | |
| SCHEMBL13541624 | 0.95 | ALDH1A1 (0.42) | NAAATSHRCYP3A4MAPK1ALDH1A1 | |
| SCHEMBL12903327 | 0.93 | NAAA (0.40) | NAAATSHREPHX1ALDH1A1LMNA | |
| SCHEMBL9927889 | 0.90 | FAAH (0.46) | LMNAPRKCA | |
| SCHEMBL13748507 | 0.90 | ALOX12 (0.38) | NAAATSHRCYP3A4ALDH1A1PRKCA | |
| SCHEMBL1949595 | 0.90 | ALOX12 (0.38) | NAAATSHRCYP3A4ALDH1A1PRKCA | |
| SCHEMBL863059 | 0.90 | KMT2A (0.41) | NAAATSHREPHX1ALDH1A1LMNA | |
| SCHEMBL5821258 | 0.90 | KMT2A (0.41) | NAAATSHREPHX1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113924124-A | Physiologically active substance bound to biotin moiety and composition for oral administration comprising the same | D&D制药技术股份有限公司 | 2022-01-11 | — | — | CN | claimed |
| US-10653709-B2 | Methods of folding a graft copolymer with dual anticancer drugs and related applications | NORTH CAROLINA STATE UNIVERSITY (US) | 2020-05-19 | — | — | US | claimed |
| US-20170080098-A1 | METHODS OF FOLDING A GRAFT COPOLYMER WITH DUAL ANTICANCER DRUGS AND RELATED APPLICATIONS | NORTH CAROLINA STATE UNIVERSITY (US) | 2017-03-23 | — | — | US | claimed |
| WO-2015179402-A1 | METHODS OF FOLDING A GRAFT COPOLYMER WITH DUAL ANTICANCER DRUGS AND RELATED APPLICATIONS | NORTH CAROLINA STATE UNIVERSITY (US) | 2015-11-26 | — | — | WO | claimed |
| JP-2006522140-A | — | — | 2006-09-28 | — | — | JP | claimed |
| EP-1608380-A2 | POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS | Vectramed, Inc. (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004089311-A2 | POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS | VECTRAMED, INC. (US) | 2004-10-21 | — | — | WO | claimed |
| US-6759170-B2 | Organic carbonate additives for nonaqueous electrolyte rechargeable electrochemical cells | WILSON GREATBATCH TECHNOLOGIES, INC. | 2004-07-06 | — | — | US | claimed |
| EP-1158589-A1 | SECONDARY LITHIUM BATTERY, NEGATIVE ELECTRODE FOR SECONDARY LITHIUM BATTERY, AND PROCESS FOR PRODUCING THE NEGATIVE ELECTRODE | FUJITSU LIMITED (JP) | 2001-11-28 | — | — | EP | claimed |
| EP-0803924-B1 | Organic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells | GREATBATCH W LTD (US) | 2001-10-31 | — | — | EP | claimed |
| US-20010031396-A1 | Lithium secondary battery, anode for lithium secondary battery, and method for manufacturing the anode | FUJITSU LIMITED (JP) | 2001-10-18 | — | — | US | claimed |
| EP-0996187-A1 | Organic carbonate additives for nonaqueous electrolyte rechargeable cells | WILSON GREATBATCH LTD. (US) | 2000-04-26 | — | — | EP | claimed |
| EP-0803924-A2 | Organic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells | WILSON GREATBATCH LTD. (US) | 1997-10-29 | — | — | EP | claimed |
| US-11894518-B2 | Electrolytes for stable cycling of high capacity lithium based batteries | IONBLOX, INC. | 2024-02-06 | — | — | US | disclosed |
| CN-113924124-A | Physiologically active substance bound to biotin moiety and composition for oral administration comprising the same | D&D制药技术股份有限公司 | 2022-01-11 | — | — | CN | disclosed |
| US-20210376383-A1 | ELECTROLYTES FOR STABLE CYCLING OF HIGH CAPACITY LITHIUM BASED BATTERIES | IONBLOX, INC. | 2021-12-02 | — | — | US | disclosed |
| EP-1158589-A1 | SECONDARY LITHIUM BATTERY, NEGATIVE ELECTRODE FOR SECONDARY LITHIUM BATTERY, AND PROCESS FOR PRODUCING THE NEGATIVE ELECTRODE | FUJITSU LIMITED (JP) | 2001-11-28 | — | — | EP | disclosed |
| US-20010031396-A1 | Lithium secondary battery, anode for lithium secondary battery, and method for manufacturing the anode | FUJITSU LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
| WO-2000064486-A2 | ENZYMATICALLY ACTIVATED POLYMERIC DRUG CONJUGATES | VECTRAMED, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| US-5998065-A | N-OXYIMIDE ADDITIVE | FUJITSU LIMITED (JP) | 1999-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170080098-A1 | METHODS OF FOLDING A GRAFT COPOLYMER WITH DUAL ANTICANCER DRUGS AND RELATED APPLICATIONS | MCL1, BCL2L1, PDIA6 | NAAA 2601/4885TSHR 4556/4885TP53 28/4885 |
| US-10653709-B2 | Methods of folding a graft copolymer with dual anticancer drugs and related applications | MCL1, BCL2L1, PDIA6 | NAAA 2601/4885TSHR 4556/4885TP53 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.